col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


172 Results       Page 1

 [1] 
Elsevier: Cell Reports Medicine
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―08 Longitudinal analysis of the lung proteome reveals persistent repair months after mild to moderate COVID-19 Shreya M. Kanth, Julio A. Huapaya, Salina Gairhe, Honghui Wang, Xin Tian, Cumhur Y. Demirkale, et al. (+33)
2 [GO] 2024―May―22 SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire Alison Tarke, Parham Ramezani-Rad, Tertuliano Alves Pereira Neto, Yeji Lee, Vanessa Silva-Moraes, Benjamin Goodwin, et al. (+10)
3 [GO] 2024―May―17 Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies Daniel J. Sheward, Pradeepa Pushparaj, Hrishikesh Das, Allison J. Greaney, Changil Kim, Sungyong Kim, et al. (+14)
4 [GO] 2024―May―14 SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson’s disease in human dopaminergic neurons and a mouse model Bina Lee, Ha Nyeoung Choi, Young Hyun Che, Myungjun Ko, Hye Min Seong, Min Gi Jo, et al. (+21)
5 [GO] 2024―May―08 A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity Chang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, Piyada Supasa, Helen M.E. Duyvesteyn, Helen M. Ginn, et al. (+23)
6 [GO] 2024―Apr―16 The gonadal niche safeguards human fetal germline cell development following maternal SARS-CoV-2 infection Shijun Shen, Mengting Wang, Xiaocui Li, Beiying Wang, Wei Hong, Wei Li, et al. (+15)
7 [GO] 2024―Mar―21 In silico clinical studies for optimal COVID-19 vaccination schedules in patients with cancer Chrysovalantis Voutouri, C. Corey Hardin, Vivek Naranbhai, Mohammad R. Nikmaneshi, Melin J. Khandekar, Justin F. Gainor, et al. (+3)
8 [GO] 2024―Mar―21 SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 or XBB.1.5 Anass Abbad, Temima Yellin, Gagandeep Singh, Miriam Fried, Ariel Raskin, Johnstone Tcheou, et al. (+22)
9 [GO] 2024―Feb―29 Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD Zezhong Liu, Jie Zhou, Weijie Wang, Guangxu Zhang, Lixiao Xing, Keqiang Zhang, et al. (+9)
10 [GO] 2024―Jan―16 Integration of individualized and population-level molecular epidemiology data to model COVID-19 outcomes Ted Ling-Hu, Lacy M. Simons, Taylor J. Dean, Estefany Rios-Guzman, Matthew T. Caputo, Arghavan Alisoltani, et al. (+11)
11 [GO] 2023―Nov―30 A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection Lucas J. Adams, Laura A. VanBlargan, Zhuoming Liu, Pavlo Gilchuk, Haiyan Zhao, Rita E. Chen, et al. (+10)
12 [GO] 2023―Nov―27 Antigen-specific T cell responses in SARS-CoV-2 mRNA-vaccinated children Jordan D. Philpott, Jordan Miller, Brittany P. Boribong, Saeina Charles, Jameson P. Davis, Simon Kazimierczyk, et al. (+6)
13 [GO] 2023―Nov―21 Immune imprinting as a barrier to effective COVID-19 vaccines Julia N. Faraone, Shan-Lu Liu
14 [GO] 2023―Nov―08 RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity Roberta Angioni, Matteo Bonfanti, Nicolò Caporale, Ricardo Sánchez-Rodríguez, Fabio Munari, Aurora Savino, et al. (+23)
15 [GO] 2023―Nov―06 SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypes Steven C. Wall, Naveenchandra Suryadevara, Changil Kim, Andrea R. Shiakolas, Clinton M. Holt, Emma B. Irbe, et al. (+11)
16 [GO] 2023―Oct―30 Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine Qian Wang, Yicheng Guo, Anthony R. Tam, Riccardo Valdez, Aubree Gordon, Lihong Liu, David D. Ho
17 [GO] 2023―Oct―26 Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID Kaiming Wang, Mobin Khoramjoo, Karthik Srinivasan, Paul M.K. Gordon, Rupasri Mandal, Dana Jackson, et al. (+7)
18 [GO] 2023―Sep―15 Association between BNT162b2 and CoronaVac vaccination and risk of CVD and mortality after COVID-19 infection: A population-based cohort study Eric Yuk Fai Wan, Anna Hoi Ying Mok, Vincent Ka Chun Yan, Cheyenne I. Ying Chan, Boyuan Wang, Francisco Tsz Tsun Lai, et al. (+8)
19 [GO] 2023―Aug―15 Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 study Wataru Akahata, Takashi Sekida, Takuto Nogimori, Hirotaka Ode, Tomokazu Tamura, Kaoru Kono, et al. (+15)
20 [GO] 2023―Aug―12 CYP19A1 mediates severe SARS-CoV-2 disease outcome in males Stephanie Stanelle-Bertram, Sebastian Beck, Nancy Kouassi Mounogou, Berfin Schaumburg, Fabian Stoll, Amirah Al Jawazneh, et al. (+51)
21 [GO] 2023―Aug―07 mRNA vaccination boosts S-specific T cell memory and promotes expansion of CD45RAint TEMRA-like CD8+ T cells in COVID-19 recovered individuals Koshlan Mayer-Blackwell, Heeju Ryu, Amy S. Codd, K. Rachael Parks, Hugh R. MacMillan, Kristen W. Cohen, et al. (+12)
22 [GO] 2023―Jul―18 Obesity negatively impacts maintenance of antibody response to COVID-19 vaccines Camille Chauvin, Sruthi Vijaya Retnakumar, Jagadeesh Bayry
23 [GO] 2023―Jul―17 Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo Rohan Narayan, Mansi Sharma, Rajesh Yadav, Abhijith Biji, Oyahida Khatun, Sumandeep Kaur, et al. (+13)
24 [GO] 2023―May―29 Targets and cross-reactivity of human T cell recognition of Common Cold Coronaviruses Alison Tarke, Yun Zhang, Nils Methot, Tara M. Narowski, Elizabeth Phillips, Simon Mallal, et al. (+8)
25 [GO] 2023―May―29 GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomised placebo-controlled phase 2 trial (COVITAR) Stefania Capone, Francesco M. Fusco, Stefano Milleri, Silvio Borrè, Sergio Carbonara, Sergio Lo Caputo, et al. (+32)
26 [GO] 2023―May―23 Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients Joann Diray-Arce, Slim Fourati, Naresh Doni Jayavelu, Ravi Patel, Cole Maguire, Ana C. Chang, et al. (+44)
27 [GO] 2023―Apr―25 Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines Paulina Kaplonek, Yixiang Deng, Jessica Shih-Lu Lee, Heather J. Zar, Dace Zavadska, Marina Johnson, et al. (+3)
28 [GO] 2023―Apr―22 Nucleic acid biomarkers of immune response and cell and tissue damage in children with COVID-19 and MIS-C Conor J. Loy, Alicia Sotomayor-Gonzalez, Venice Servellita, Jenny Nguyen, Joan Lenz, Sanchita Bhattacharya, et al. (+23)
29 [GO] 2023―Mar―27 Robust SARS-CoV-2 T cell responses with common TCRαβ motifs towards COVID-19 vaccines in haematological malignancy patients impacting B cell immunity Thi H O Nguyen, Louise C Rowntree, Lilith F Allen, Brendon Y Chua, Lukasz Kedzierski, Chhay Lim, et al. (+49)
30 [GO] 2023―Mar―27 Ad26.COV2.S and SARS-CoV-2 Spike Protein Ferritin Nanoparticle Vaccine Protect Against SARS-CoV-2 Omicron BA.5 Challenge in Macaques Jingyou Yu, Paul V. Thomas, Michaela Sciacca, Cindy Wu, Jinyan Liu, Xuan He, et al. (+34)
31 [GO] 2023―Mar―21 An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB Qingwen He, Lili Wu, Zepeng Xu, Xiaoyun Wang, Yufeng Xie, Yan Chai, et al. (+10)
32 [GO] 2023―Feb―17 A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines. Feargal J. Ryan, Todd S. Norton, Conor McCafferty, Stephen J. Blake, Natalie E. Stevens, Jane James, et al. (+21)
33 [GO] 2023―Feb―07 A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile. Gérémy Sannier, Alexandre Nicolas, Mathieu Dubé, Lorie Marchitto, Manon Nayrac, Olivier Tastet, et al. (+32)
34 [GO] 2023―Jan―27 Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection Chrispin Chaguza, Anne M. Hahn, Mary E. Petrone, Shuntai Zhou, David Ferguson, Mallery I. Breban, et al. (+8)
35 [GO] 2023―Jan―25 Dynamic Activity in cis-Regulatory Elements of Leukocytes Identifies Transcription Factor Activation and Stratifies COVID-19 Severity in ICU Patients Michael Tun Yin Lam, Sascha H. Duttke, Mazen F. Odish, Hiep D. Le, Emily A. Hansen, Celina T. Nguyen, et al. (+20)
36 [GO] 2023―Jan―23 COVID-19 vaccines versus pediatric hospitalization Jaime S. Rosa Duque, Daniel Leung, Ka Man Yip, Derek H.L. Lee, Hung-kwan So, Wilfred H.S. Wong, Yu Lung Lau
37 [GO] 2022―Dec―29 The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice Irfan Ullah, Guillaume Beaudoin-Bussières, Kelly Symmes, Marc Cloutier, Eric Ducas, Alexandra Tauzin, et al. (+10)
38 [GO] 2022―Dec―22 Impact of SARS-CoV-2 exposure history on the T cell and IgG response Roanne Keeton, Marius B. Tincho, Akiko Suzuki, Ntombi Benede, Amkele Ngomti, Richard Baguma, et al. (+12)
39 [GO] 2022―Dec―22 Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera, regardless of the infecting variant Simone I. Richardson, Prudence Kgagudi, Nelia P. Manamela, Haajira Kaldine, Elizabeth M. Venter, Thanusha Pillay, et al. (+16)
40 [GO] 2022―Dec―20 Preventing the next pandemic: Use of artificial intelligence for epidemic monitoring and alerts C. Raina MacIntyre, Samsung Lim, Ashley Quigley
41 [GO] 2022―Dec―15 AZD1222-induced mucosal immune responses are influenced by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection Anastasia A. Aksyuk, Himanshu Bansal, Deidre Wilkins, Ann Marie Stanley, Stephanie Sproule, Jill Maaske, et al. (+5)
42 [GO] 2022―Nov―21 Neutrophil Profiles of Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children Brittany P. Boribong, Thomas J. LaSalle, Yannic C. Bartsch, Felix Ellett, Maggie E. Loiselle, Jameson P. Davis, et al. (+12)
43 [GO] 2022―Nov―17 Human Early Syncytiotrophoblasts Are Highly Susceptible to SARS-CoV-2 Infection Degong Ruan, Zi-Wei Ye, Shuofeng Yuan, Zhuoxuan Li, Weiyu Zhang, Chon Phin Ong, et al. (+13)
44 [GO] 2022―Nov―17 Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4 and BA.5 in patients receiving monoclonal antibodies Timothée Bruel, Karl Stéfic, Yann Nguyen, Donatella Toniutti, Isabelle Staropoli, Françoise Porrot, et al. (+20)
45 [GO] 2022―Nov―16 Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment Cedric Bosteels, Karel F.A. Van Damme, Elisabeth De Leeuw, Jozefien Declercq, Bastiaan Maes, Victor Bosteels, et al. (+27)
46 [GO] 2022―Nov―16 Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design Blake M. Hauser, Jared Feldman, Maya Sangesland, Larance Ronsard, Kerri J. St. Denis, Maegan L. Sheehan, et al. (+11)
47 [GO] 2022―Nov―16 T follicular helper cells and the germinal centre are required for memory B cell formation and humoral immunity after ChAdOx1 nCoV-19 vaccination. William S. Foster, Jia Le Lee, Nazia Thakur, Joseph Newman, Alexandra J. Spencer, Sophie Davies, et al. (+11)
48 [GO] 2022―Oct―24 Nucleocapsid-specific antibody function is associated with therapeutic benefit from Covid-19 Convalescent plasma therapy Jonathan D. Herman, Chuangqi Wang, John Stephen Burke, Yonatan Zur, Hacheming Compere, Jaewon Kang, et al. (+14)
49 [GO] 2022―Oct―06 A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or Inactive virus COVID-19 Vaccines Joey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran, Adeline Chia, Nicole Tan, Eng Sing Lee, et al. (+7)
50 [GO] 2022―Sep―29 A Molecularly Engineered, Broad-spectrum Anti-coronavirus Lectin Inhibits SARS-CoV-2 and MERS-CoV Infection In Vivo Jasper Fuk-Woo Chan, Yoo Jin Oh, Shuofeng Yuan, Hin Chu, Man-Lung Yeung, Daniel Canena, et al. (+34)
51 [GO] 2022―Sep―27 Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer Annika Fendler, Scott T.C. Shepherd, Lewis Au, Mary Wu, Ruth Harvey, Katalin A. Wilkinson, et al. (+58)
52 [GO] 2022―Sep―27 Machine learning for determining lateral flow device results for testing of SARS-CoV-2 infection in asymptomatic populations Camila C.S. Caiado, Mark Branigan, Paul Lewis-Borman, Nishali Patel, Tom Fowler, Anna Dijkstra, et al. (+13)
53 [GO] 2022―Sep―26 Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with severity in hospitalized COVID-19 patients Thomas J. LaSalle, Anna L.K. Gonye, Samuel S. Freeman, Paulina Kaplonek, Irena Gushterova, Kyle R. Kays, et al. (+26)
54 [GO] 2022―Sep―07 Disentangling the cognitive, physical, and mental health sequalae of COVID-19. Conor J. Wild, Loretta Norton, David K. Menon, David A. Ripsman, Richard H. Swartz, Adrian M. Owen
55 [GO] 2022―Aug―29 Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2 Jasper Fuk-Woo Chan, Bingjie Hu, Yue Chai, Huiping Shuai, Huan Liu, Jialu Shi, et al. (+20)
56 [GO] 2022―Aug―25 Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people Helen Parry, Rachel Bruton, Reni Ayodele, Penny Sylla, Graham McIlroy, Nicola Logan, et al. (+7)
57 [GO] 2022―Aug―16 Antibody therapy reverses biological signatures of COVID-19 progression M. Cyrus Maher, Leah B. Soriaga, Anil Gupta, Yi-Pei Chen, Julia di Iulio, Sarah Ledoux, et al. (+17)
58 [GO] 2022―Aug―16 Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection Andreas Heyer, Thomas Günther, Alexis Robitaille, Marc Lütgehetmann, Marylyn M. Addo, Dominik Jarczak, et al. (+5)
59 [GO] 2022―Aug―15 Multiple BCG vaccinations for prevention of COVID-19 and other infectious diseases in Type 1 diabetes Denise L. Faustman, Amanda Lee, Emma R. Hostetter, Anna Aristarkhova, Nathan C. Ng, Gabriella F. Shpilsky, et al. (+8)
60 [GO] 2022―Jul―19 Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine Leonie M. Weskamm, Anahita Fathi, Matthijs P. Raadsen, Anna Z. Mykytyn, Till Koch, Michael Spohn, et al. (+16)
61 [GO] 2022―Jul―01 Resolving SARS-CoV-2 CD4+ T cell specificity via reverse epitope discovery Mikhail V. Pogorelyy, Elisa Rosati, Anastasia A. Minervina, Robert C. Mettelman, Alexander Scheffold, Andre Franke, et al. (+2)
62 [GO] 2022―Jun―28 Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 Dorien Feyaerts, Julien Hédou, Joshua Gillard, Han Chen, Eileen S. Tsai, Laura S. Peterson, et al. (+35)
63 [GO] 2022―Jun―28 Parenteral mucosal chemokine adjuvant enhances synDNA vaccine-mediated peripheral and mucosal responses to SARS-CoV-2 and provides heterologous protection in vivo Ebony N. Gary, Nicholas J. Tursi, Bryce Warner, Elizabeth M. Parzych, Ali R. Ali, Drew Frase, et al. (+9)
64 [GO] 2022―Jun―27 CD8+ T cells: an ineffective armor against prolonged COVID-19 in cancer patients Oliver Van Oekelen, Samir Parekh
65 [GO] 2022―Jun―21 The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19 Christoph Schultheiß, Edith Willscher, Lisa Paschold, Cornelia Gottschick, Bianca Klee, Svenja-Sibylla Henkes, et al. (+9)
66 [GO] 2022―Jun―20 Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection Julie Boucau, Kara W. Chew, Manish Choudhary, Rinki Deo, James Regan, James P. Flynn, et al. (+18)
67 [GO] 2022―Jun―20 Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant Kirsten E. Lyke, Robert L. Atmar, Clara Dominguez Islas, Christine M. Posavad, Daniel Szydlo, Rahul PaulChourdhury, et al. (+31)
68 [GO] 2022―Jun―09 mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes Ofer Zimmerman, Alexa Michelle Altman Doss, Paulina Kaplonek, Chieh-Yu Liang, Laura A. VanBlargan, Rita E. Chen, et al. (+22)
69 [GO] 2022―May―17 Mature neutrophils and a NFkB-to-IFN transition determine the unifying disease recovery dynamics in COVID-19 Amit Frishberg, Emma Kooistra, Melanie Nuesch-Germano, Tal Pecht, Neta Milman, Nico Reusch, et al. (+19)
70 [GO] 2022―May―17 SARS-CoV-2 Omicron variant escapes neutralising antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents. Pablo Garcia-Valtanen, Christopher M. Hope, Makutiro G. Masavuli, Arthur Eng Lip Yeow, Harikrishnan Balachandran, Zelalem A. Mekonnen, et al. (+23)
71 [GO] 2022―May―03 TNFα-producing CD4+ T cells dominate the SARS-CoV-2-specific T cell response in COVID-19 outpatients and are associated with durable antibodies Kattria van der Ploeg, Adam S. Kirosingh, Diego A.M. Mori, Saborni Chakraborty, Zicheng Hu, Benjamin L. Sievers, et al. (+16)
72 [GO] 2022―Apr―26 Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2 Lei Peng, Paul A. Renauer, Arya Ökten, Zhenhao Fang, Jonathan J. Park, Xiaoyu Zhou, et al. (+8)
73 [GO] 2022―Apr―22 Distinct Immune Cell Dynamics Correlate with the Immunogenicity and Reactogenicity of SARS-CoV-2 mRNA Vaccine Tomohiro Takano, Miwa Morikawa, Yu Adachi, Kiyomi Kabasawa, Nicolas Sax, Saya Moriyama, et al. (+12)
74 [GO] 2022―Apr―19 Consumer-grade wearables identify changes in multiple physiological systems during COVID-19 disease progression Caleb Mayer, Jonathan Tyler, Yu Fang, Christopher Flora, Elena Frank, Muneesh Tewari, et al. (+3)
75 [GO] 2022―Mar―29 Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immune responses in mild COVID-19 patients Christophe M. Capelle, Séverine Ciré, Olivia Domingues, Isabelle Ernens, Fanny Hedin, Aurélie Fischer, et al. (+19)
76 [GO] 2022―Mar―29 Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination. Grace Mantus, Lindsay E. Nyhoff, Venkata-Viswanadh Edara, Veronika I. Zarnitsyna, Caroline R. Ciric, Maria W. Flowers, et al. (+9)
77 [GO] 2022―Mar―15 COVID-19 in children: From afterthought to unknown Donato Amodio, Nicola Cotugno, Paolo Palma
78 [GO] 2022―Mar―15 Multi-omics in COVID-19: Seeing the unseen but overlooked in the clinic Tian Lu, Yingrui Wang, Tiannan Guo
79 [GO] 2022―Mar―15 More efforts are needed for background surveys of zoonotic coronaviruses in animals Liang Wang, Jing Yang, Kangtai Sun, Yuhai Bi, George F. Gao
80 [GO] 2022―Mar―15 SARS-CoV-2 variant Delta rapidly displaced variant Alpha in the United States and led to higher viral loads Alexandre Bolze, Shishi Luo, Simon White, Elizabeth T. Cirulli, Dana Wyman, Andrew Dei Rossi, et al. (+17)
81 [GO] 2022―Mar―15 Two years of pandemic: A wealth of data and many remaining questions Sara Hamilton, Isabel Goldman, Kristan van der Vos, Sha Yu
82 [GO] 2022―Mar―11 Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA Rebecca Earnest, Rockib Uddin, Nicholas Matluk, Nicholas Renzette, Sarah E. Turbett, Katherine J. Siddle, et al. (+44)
83 [GO] 2022―Mar―04 Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections Aneesh Chandran, Joshua Rosenheim, Gayathri Nageswaran, Leo Swadling, Gabriele Pollara, Rishi K. Gupta, et al. (+22)
84 [GO] 2022―Feb―25 Development and validation of SCOPE score: a clinical score to predict progression of COVID-19 pneumonia to severe respiratory failure Evangelos J. Giamarellos-Bourboulis, Garyfallia Poulakou, Aline de Nooijer, Haralampos Milionis, Simeon Metallidis, Michalis Ploumidis, et al. (+33)
85 [GO] 2022―Feb―25 Count on us: T-cells in SARS-CoV-2 infection and vaccination Katherine Kedzierska, Paul G. Thomas
86 [GO] 2022―Feb―21 The role of schools in driving SARS-CoV-2 transmission: not just an open-and-shut case Laura F. White, Eleanor J. Murray, Arijit Chakravarty
87 [GO] 2022―Feb―11 Antiviral agents for the treatment of COVID-19: progress and challenges Manmeet Singh, Emmie de Wit
88 [GO] 2022―Feb―10 Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern Dale Kitchin, Simone I. Richardson, Mieke A. van der Mescht, Thopisang Motlou, Nonkululeko Mzindle, Thandeka Moyo-Gwete, et al. (+19)
89 [GO] 2022―Feb―09 Treating COVID-19: Evolving approaches to evidence in a pandemic Cheryl K. Lee, Louis T. Merriam, Jeffrey C. Pearson, Michael S. Lipnick, William McKleroy, Edy Y. Kim
90 [GO] 2022―Feb―08 Fc effector cross-reactivity: A hidden arsenal against SARS-CoV-2’s evasive maneuvering Michael W. Grunst, Pradeep D. Uchil
91 [GO] 2022―Jan―24 System-wide transcriptome damage and tissue identity loss in COVID-19 patients Jiwoon Park, Jonathan Foox, Tyler Hether, David C. Danko, Sarah Warren, Youngmi Kim, et al. (+42)
92 [GO] 2022―Jan―24 Clinical course impacts early kinetics and long-term magnitude and amplitude of SARS-CoV-2 neutralizing antibodies beyond one year after infection Edwards Pradenas, Benjamin Trinité, Víctor Urrea, Silvia Marfil, Ferran Tarrés-Freixas, Raquel Ortiz, et al. (+16)
93 [GO] 2022―Jan―24 mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant Venkata-Viswanadh Edara, Kelly E. Manning, Madison Ellis, Lilin Lai, Kathryn M. Moore, Stephanie L. Foster, et al. (+22)
94 [GO] 2022―Jan―24 Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor binding domain Nathaniel L. Miller, Thomas Clark, Rahul Raman, Ram Sasisekharan
95 [GO] 2022―Jan―24 Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects Macaques from infection Guidenn Sulbaran, Pauline Maisonnasse, Axelle Amen, Gregory Effantin, Delphine Guilligay, Nathalie Dereuddre-Bosquet, et al. (+25)
96 [GO] 2022―Jan―19 Neutralizing antibody-independent SARS-CoV-2 control correlated with intranasal vaccine-induced CD8+ T-cell responses Hiroshi Ishii, Takushi Nomura, Hiroyuki Yamamoto, Masako Nishizawa, Trang Thi Thu Hau, Shigeyoshi Harada, et al. (+18)
97 [GO] 2022―Jan―18 Potential role of neurofilament in COVID-19 and preeclampsia Athina Samara, Eric Herlenius, Patrick O’ Brien, Asma Khalil
98 [GO] 2022―Jan―17 SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity Simone I. Richardson, Nelia P. Manamela, Boitumelo M. Motsoeneng, Haajira Kaldine, Frances Ayres, Zanele Makhado, et al. (+13)
99 [GO] 2021―Dec―14 A Single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern Marit J. van Gils, Hugo D.G. van Willigen, Elke Wynberg, Alvin X. Han, Karlijn van der Straten, Judith A. Burger, et al. (+21)
100 [GO] 2021―Dec―02 Critically ill COVID-19 patients exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 viral burden in the lung Anthony R. Cillo, Ashwin Somasundaram, Feng Shan, Carly Cardello, Creg J. Workman, Georgios D. Kitsios, et al. (+23)
101 [GO] 2021―Dec―02 Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination Juliana Gonçalves, A. Margarida Juliano, Nádia Charepe, Marta Alenquer, Diogo Athayde, Filipe Ferreira, et al. (+4)
102 [GO] 2021―Nov―04 SARS-CoV-2 can infect and propagate in human placenta explants Amal Fahmi, Melanie Brügger, Thomas Démoulins, Beatrice Zumkehr, Blandina I. Oliveira Esteves, Lisamaria Bracher, et al. (+5)
103 [GO] 2021―Oct―27 The systemic inflammatory landscape of COVID19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in-utero SARS-CoV-2 Suan-Sin Foo, Mary Catherine Cambou, Thalia Mok, Viviana M. Fajardo, Kyle L. Jung, Trevon Fuller, et al. (+33)
104 [GO] 2021―Oct―27 Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learning Shira Doron, Robin R. Ingalls, Anne Beauchamp, Jesse S. Boehm, Helen W. Boucher, Linda H. Chow, et al. (+7)
105 [GO] 2021―Oct―25 A pathogen-like antigen based vaccine confers immune protection against SARS-CoV-2 in non-human primates Chang Guo, Yanan Peng, Lin Lin, Xiaoyan Pan, Mengqi Fang, Yun Zhao, et al. (+16)
106 [GO] 2021―Oct―25 Beta RBD Boost Broadens Antibody-Mediated Protection Against SARS-CoV-2 Variants in Animal Models Daniel J. Sheward, Marco Mandolesi, Egon Urgard, Changil Kim, Leo Hanke, Laura Perez Vidakovics, et al. (+7)
107 [GO] 2021―Sep―28 Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model Ami Patel, Jewell N. Walters, Emma L. Reuschel, Katherine Schultheis, Elizabeth Parzych, Ebony N. Gary, et al. (+36)
108 [GO] 2021―Sep―28 Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers Tsuguhisa Nakayama, Ivan T. Lee, Sizun Jiang, Matthias S. Matter, Carol H. Yan, Jonathan B. Overdevest, et al. (+37)
109 [GO] 2021―Aug―31 Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination Matthew J. Gorman, Nita Patel, Mimi Guebre-Xabier, Alex L. Zhu, Caroline Atyeo, Krista M. Pullen, et al. (+25)
110 [GO] 2021―Aug―17 SARS-CoV-2 infection of islet β cells: Evidence and implications Amy L. Clark, Raghavendra G. Mirmira
111 [GO] 2021―Jul―28 Performance of Crisis Standards of Care Guidelines in a Cohort of Critically Ill COVID-19 Patients in the United States Julia L. Jezmir, Maheetha Bharadwaj, Alexander Chaitoff, Bradford Diephuis, Conor P. Crowley, Sandeep P. Kishore, et al. (+10)
112 [GO] 2021―Jul―27 Combating information chaos: a case for collaborative clinical guidelines in a pandemic C. Lee Cohen, Katherine H. Walker, Mina Hsiang, Paul D. Sonenthal, Elisabeth D. Riviello, Shada A. Rouhani, et al. (+3)
113 [GO] 2021―Jul―21 Longitudinal Metabolomics of Human Plasma Reveals Prognostic Markers of COVID-19 Disease Severity Miriam Sindelar, Ethan Stancliffe, Michaela Schwaiger-Haber, Dhanalakshmi S. Anbukumar, Kayla Adkins-Travis, Charles W. Goss, et al. (+7)
114 [GO] 2021―Jul―03 Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells Kristen W. Cohen, Susanne L. Linderman, Zoe Moodie, Julie Czartoski, Lilin Lai, Grace Mantus, et al. (+27)
115 [GO] 2021―Jul―02 Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals Alison Tarke, John Sidney, Nils Methot, Esther Dawen Yu, Yun Zhang, Jennifer M. Dan, et al. (+15)
116 [GO] 2021―Jun―15 Serological Analysis Reveals an Imbalanced IgG Subclass Composition Associated with COVID-19 Disease Severity Jennifer L. Yates, Dylan J. Ehrbar, Danielle T. Hunt, Roxanne C. Girardin, Alan P. Dupuis, Anne F. Payne, et al. (+17)
117 [GO] 2021―Jun―09 Young infants exhibit robust functional antibody responses and restrained IFN-γ production to SARS-CoV-2 Anu Goenka, Alice Halliday, Michaela Gregorova, Emily Milodowski, Amy Thomas, Maia Kavanagh Williamson, et al. (+20)
118 [GO] 2021―May―28 Broad Auto-Reactive IgM Responses are Common in Critically Ill Patients Including Those with COVID-19 Andrew Kam Ho Wong, Isaac Woodhouse, Frank Schneider, Deanna A. Kulpa, Guido Silvestri, Cheryl L. Maier
119 [GO] 2021―May―27 Intrinsic Signal Amplification by Type-III CRISPR-Cas Systems Provides a Sequence-Specific SARS-CoV-2 Diagnostic Andrew Santiago-Frangos, Laina N. Hall, Anna Nemudraia, Artem Nemudryi, Pushya Krishna, Tanner Wiegand, et al. (+9)
120 [GO] 2021―May―21 Landscape of epitopes targeted by T cells in 852 convalescent COVID-19 patients: Meta-analysis, immunoprevalence and web platform Ahmed Abdul Q귮r, Syed Faraz Ahmed, Matthew R. McKay
121 [GO] 2021―May―21 Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions Andrea R. Shiakolas, Kevin J. Kramer, Daniel Wrapp, Simone I. Richardson, Alexandra Schäfer, Steven Wall, et al. (+25)
122 [GO] 2021―May―18 SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition Daniel M. Altmann, Catherine J. Reynolds, Rosemary J. Boyton
123 [GO] 2021―May―16 Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests Yutaro Yamaoka, Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Rikako Funabashi, Koji Okudela, Sayaka Kikuchi, et al. (+23)
124 [GO] 2021―May―09 Decay of Fc-dependent antibody functions after mild to moderate COVID-19 Wen Shi Lee, Kevin John Selva, Samantha K. Davis, Bruce D. Wines, Arnold Reynaldi, Robyn Esterbauer, et al. (+10)
125 [GO] 2021―May―06 Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV2 infection M. Roussel, J. Ferrant, F. Reizine, S. Le Gallou, J. Dulong, S. Carl, et al. (+19)
126 [GO] 2021―May―05 Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to eight months post-symptom onset Sai Priya Anand, Jérémie Prévost, Manon Nayrac, Guillaume Beaudoin-Bussières, Mehdi Benlarbi, Romain Gasser, et al. (+18)
127 [GO] 2021―May―03 Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms Eric Song, Christopher M. Bartley, Ryan D. Chow, Thomas T. Ngo, Ruoyi Jiang, Colin R. Zamecnik, et al. (+40)
128 [GO] 2021―May―03 Longitudinal proteomic analysis of plasma from patients with severe COVID-19 reveal patient survival-associated signatures, tissue-specific cell death, and cell-cell interactions Michael R. Filbin, Arnav Mehta, Alexis M. Schneider, Kyle R. Kays, Jamey R. Guess, Matteo Gentili, et al. (+37)
129 [GO] 2021―Apr―21 Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies. Jérémy Dufloo, Ludivine Grzelak, Isabelle Staropoli, Yoann Madec, Laura Tondeur, François Anna, et al. (+14)
130 [GO] 2021―Apr―20 Soluble Interleukin-6 Receptor in the COVID-19 Cytokine Storm Syndrome Luke Y.C. Chen, Catherine M. Biggs, Shahin Jamal, Sophie Stukas, Cheryl L. Wellington, Mypinder S. Sekhon
131 [GO] 2021―Apr―19 BNT162b2 Vaccination Effectively Prevents the Rapid Rise of SARS-CoV-2 Variant B.1.1.7 in high risk populations in Israel A. Munitz, M. Yechezkel, Y. Dickstein, D. Yamin, M. Gerlic
132 [GO] 2021―Apr―08 Training during a Pandemic
133 [GO] 2021―Apr―05 Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19 disease Whitney E. Harrington, Olesya Trakhimets, Daniela V. Andrade, Nicholas Dambrauskas, Andrew Raappana, Yonghou Jiang, et al. (+14)
134 [GO] 2021―Apr―05 SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses Marco Mandolesi, Daniel J. Sheward, Leo Hanke, Junjie Ma, Pradeepa Pushparaj, Laura Perez Vidakovics, et al. (+9)
135 [GO] 2021―Apr―05 Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016 Tyler N. Starr, Allison J. Greaney, Adam S. Dingens, Jesse D. Bloom
136 [GO] 2021―Mar―23 Spatial mapping of SARS-CoV-2 and H1N1 Lung Injury Identifies Differential Transcriptional Signatures C. Margaroli, P. Benson, N.S. Sharma, M.C. Madison, S.W. Robison, N. Arora, et al. (+5)
137 [GO] 2021―Mar―20 A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques Ahmed O. Hassan, Friederike Feldmann, Haiyan Zhao, David T. Curiel, Atsushi Okumura, Tsing-Lee Tang-Huau, et al. (+10)
138 [GO] 2021―Mar―19 A dual antibody test for accurate surveillance of SARS-CoV-2 exposure rates Emmanuelle V. LeBlanc, Che C. Colpitts
139 [GO] 2021―Mar―15 Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients Philipp K. Buehler, Annelies S. Zinkernagel, Daniel A. Hofmaenner, Pedro David Wendel Garcia, Claudio T. Acevedo, Alejandro Gómez-Mejia, et al. (+8)
140 [GO] 2021―Mar―15 Long-term persistence of RBD-positive memory B cells encoding neutralising antibodies in SARS-CoV-2 infection Arunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, Mohamed Hammoud, Chaturaka Rodrigo, Elizabeth Keoshkerian, et al. (+25)
141 [GO] 2021―Mar―01 Low awareness of past SARS-CoV-2 infection in healthy plasma donors Katja van den Hurk, Eva-Maria Merz, Femmeke J. Prinsze, Marloes L.C. Spekman, Franke A. Quee, Steven Ramondt, et al. (+5)
142 [GO] 2021―Feb―25 TOTAL PREDICTED MHC-I EPITOPE LOAD IS INVERSELY ASSOCIATED WITH POPULATION MORTALITY FROM SARS-COV-2 Eric A. Wilson, Gabrielle Hirneise, Abhishek Singharoy, Karen S. Anderson
143 [GO] 2021―Feb―25 Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters Michael S. Piepenbrink, Jun-Gyu Park, Fatai S. Oladunni, Ashlesha Deshpande, Madhubanti Basu, Sanghita Sarkar, et al. (+14)
144 [GO] 2021―Feb―07 Integrated immune dynamics define correlates of COVID-19 severity and antibody responses Marios Koutsakos, Louise C. Rowntree, Luca Hensen, Brendon Y. Chua, Carolien E. van de Sandt, Jennifer R. Habel, et al. (+38)
145 [GO] 2021―Jan―26 Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases Alison Tarke, John Sidney, Conner K. Kidd, Jennifer M. Dan, Sydney I. Ramirez, Esther Dawen Yu, et al. (+16)
146 [GO] 2021―Jan―19 Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses Jason T. Ladner, Sierra N. Henson, Annalee S. Boyle, Anna L. Engelbrektson, Zane W. Fink, Fatima Rahee, et al. (+16)
147 [GO] 2021―Jan―18 Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic COVID-19 patients Yun Shan Goh, Jean-Marc Chavatte, Alicia Lim Jieling, Bernett Lee, Pei Xiang Hor, Siti Naqiah Amrun, et al. (+18)
148 [GO] 2021―Jan―18 Use of machine learning to identify a T cell response to SARS-CoV-2 M.S. Shoukat, A.D. Foers, S. Woodmansey, S.C. Evans, A. Fowler, E. Soilleux
149 [GO] 2021―Jan―15 The Endangered Physician-Scientist and COVID-19 Rajesh C. Rao, Brian J. Dlouhy, Brian C. Capell, Oluwaseun Akeju
150 [GO] 2021―Jan―15 SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population Thomas Vogl, Sigal Leviatan, Eran Segal
151 [GO] 2020―Dec―26 A distinct innate immune signature marks progression from mild to severe COVID-19 Stéphane Chevrier, Yves Zurbuchen, Carlo Cervia, Sarah Adamo, Miro E. Raeber, Natalie de Souza, et al. (+10)
152 [GO] 2020―Dec―05 Convalescent Plasma-Mediated Resolution of COVID-19 in a Patient with Humoral Immunodeficiency Kazuhito Honjo, Ronnie M. Russell, Ran Li, Weimin Liu, Regina Stoltz, Edlue M. Tabengwa, et al. (+17)
153 [GO] 2020―Nov―17 Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury Neha Tabassum, Hua Zhang, Justin Stebbing
154 [GO] 2020―Oct―30 Inflammatory biomarker trends predict respiratory decline in COVID-19 patients Alisa A. Mueller, Tomoyoshi Tamura, Conor P. Crowley, Jeremy R. DeGrado, Hibah Haider, Julia L. Jezmir, et al. (+4)
155 [GO] 2020―Oct―30 Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells Alexander Carpinteiro, Michael J. Edwards, Markus Hoffmann, Georg Kochs, Barbara Gripp, Sebastian Weigang, et al. (+21)
156 [GO] 2020―Sep―30 Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike Jérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, Jonathan Richard, Ralf Duerr, Annemarie Laumaea, et al. (+29)
157 [GO] 2020―Sep―24 ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens Colin R. Zamecnik, Jayant V. Rajan, Kevin A. Yamauchi, Sabrina A. Mann, Rita P. Loudermilk, Gavin M. Sowa, et al. (+16)
158 [GO] 2020―Sep―22 Oral SARS-CoV-2 inoculation establishes subclinical respiratory infection with virus shedding in golden Syrian hamsters Andrew Chak-Yiu Lee, Anna Jinxia Zhang, Jasper Fuk-Woo Chan, Can Li, Zhimeng Fan, Feifei Liu, et al. (+11)
159 [GO] 2020―Sep―01 Combined point of care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G Spike Variant Petra Mlcochova, Dami Collier, Allyson Ritchie, Sonny M. Assennato, Myra Hosmillo, Neha Goel, et al. (+156)
160 [GO] 2020―Aug―31 Temporal detection and phylogenetic assessment of SARS-CoV-2 in municipal wastewater Artem Nemudryi, Anna Nemudraia, Tanner Wiegand, Kevin Surya, Murat Buyukyoruk, Calvin Cicha, et al. (+3)
161 [GO] 2020―Aug―29 Robust T cell response towards spike, membrane, and nucleocapsid SARS-CoV-2 proteins is not associated with recovery in critical COVID-19 patients Constantin J. Thieme, Moritz Anft, Krystallenia Paniskaki, Arturo Blazquez-Navarro, Adrian Doevelaar, Felix S. Seibert, et al. (+15)
162 [GO] 2020―Aug―19 SARS-CoV-2-specific T cells exhibit phenotypic features of robust helper function, lack of terminal differentiation, and high proliferative potential Jason Neidleman, Xiaoyu Luo, Julie Frouard, Guorui Xie, Gurjot Gill, Ellen S. Stein, et al. (+9)
163 [GO] 2020―Aug―05 Systems-level immunomonitoring from acute to recovery phase of severe COVID-19 Lucie Rodriguez, Pirkka T. Pekkarinen, Tadepally Lakshmikanth, Ziyang Tan, Camila Rosat Consiglio, Christian Pou, et al. (+14)
164 [GO] 2020―Aug―05 Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study Simone J.C.F.M. Moorlag, Rosanne C. van Deuren, Cornelis H. van Werkhoven, Martin Jaeger, Priya Debisarun, Esther Taks, et al. (+18)
165 [GO] 2020―Jul―21 Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia Andrés Pizzorno, Blandine Padey, Thomas Julien, Sophie Trouillet-Assant, Aurélien Traversier, Elisabeth Errazuriz-Cerda, et al. (+12)
166 [GO] 2020―Jul―15 Point of care nucleic acid testing for SARS-CoV-2 in hospitalised patients: a clinical validation trial and implementation study. Dami A. Collier, Sonny M. Assennato, Ben Warne, Nyarie Sithole, Katherine Sharrocks, Allyson Ritchie, et al. (+26)
167 [GO] 2020―Jun―29 Human iPSC-Derived Cardiomyocytes , are Susceptible to SARS-CoV-2 Infection Arun Sharma, Gustavo Garcia, Yizhou Wang, Jasmine T. Plummer, Kouki Morizono, Vaithilingaraja Arumugaswami, Clive N. Svendsen
168 [GO] 2020―Jun―23 Voices from a Pandemic
169 [GO] 2020―Jun―08 Rapid generation of neutralizing antibody responses in COVID-19 patients Mehul S. Suthar, Matthew G. Zimmerman, Robert C. Kauffman, Grace Mantus, Susanne L. Linderman, William H. Hudson, et al. (+32)
170 [GO] 2020―Jun―08 Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-term Population-Scale Immunity Mark Yarmarkovich, John M. Warrington, Alvin Farrel, John M. Maris
171 [GO] 2020―May―01 Immune mechanisms for increased risk of severe COVID-19 in Down syndrome Joaquin M. Espinosa
172 [GO] 2020―Apr―30 Adjunct immunotherapies for the management of severely ill COVID-19 patients Srinivasa Reddy Bonam, Srini V. Kaveri, Anavaj Sakuntabhai, Laurent Gilardin, Jagadeesh Bayry
 [1] 

172 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec